Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platform is a research paper published in npj Vaccines (2024). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1R01CA266783-01A1
Transfer of vaccine-induced immunity from immunocompetent stem cell donor as antiviral immunotherapy to protect high-risk transplant recipients from cytomegalovirus reactivation
National Institutes of Health
Grant: 5U19AI128913-05
Mapping Immune Responses to CMV in Renal Transplant Recipients
FWCI
1.10
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals